Company / Free Cash Flow per Share
Veracyte, Inc. Free Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
$1.63
FY2025
5-year range
-$0.64 / $1.63
FY2021-FY2025
Trend
+86.9%
vs FY2024
Sector context
#79 of 148
Health Care
What the data says
At $1.63, Veracyte, Inc.'s free cash flow per share ranks #79 of 148 in the Health Care sector. Free Cash Flow per Share has increased for 4 consecutive years, from $-0.64 in FY2021 to $1.63 in FY2025.
Based on SEC 10-K filings.
1.63 in FY2025.
Improved from $0.48 to $1.63 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#79 of 148 in Health CareTop 53% of 148This company $1.63 Sector average $5.05
▼
-67.8% below sector average
Key checks
Key Insights
- Veracyte, Inc.'s free cash flow per share has grown for 4 consecutive years.
- In FY2025, free cash flow per share increased 86.9% year-over-year.
- Ranks #79 out of 148 companies in the Health Care sector.
- Lowest free cash flow per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 6.19 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.63 | +86.9% |
| FY2024 | $0.87 | +82.9% |
| FY2023 | $0.48 | +3439.5% |
| FY2022 | -$0.01 | +97.8% |
| FY2021 | -$0.64 | -104.9% |
| FY2020 | -$0.31 | -111.7% |
| FY2019 | -$0.15 | +67.9% |
| FY2018 | -$0.46 | +53.5% |
| FY2017 | -$0.98 | +8.4% |
| FY2016 | -$1.07 | +27.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026